Here's some interesting news, hot off the presses....
Save yourself some time and go to the 3 minute mark. Or watch it all and get a laugh out of the editing (or lack thereof).
I am one of the 19 views.
Cynata are inferring that Mesoblast will fail with the FDA and GVHD.
This is another direct swipe by CYP at MSB. https://www.cynata.com/news
Someone is going to be very wrong.
Note: Rasko and Cynata have never commenced a trial with the FDA. Ever.
This clip requires a response from Mesoblast management.
Cell Therapy News/Articles, page-16225
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |